Tue, May 5, 2020

Chad Messer Maintained (AKBA) at Strong Buy with Increased Target to $18 on, May 5th, 2020

Chad Messer of Needham, Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $15 to $18 on, May 5th, 2020.

Chad has made no other calls on AKBA in the last 4 months.



There are 2 other peers that have a rating on AKBA. Out of the 2 peers that are also analyzing AKBA, 0 agree with Chad's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chad


  • Difei Yang of "Mizuho" Reiterated at Strong Buy with Decreased Target to $15 on, Wednesday, March 11th, 2020
  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $13 on, Thursday, February 20th, 2020


Similar Stocks and Investing Publications